{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:29:40Z","timestamp":1786652980567,"version":"build-2736575974"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Ophthalmol"],"published-print":{"date-parts":[[2014]]},"DOI":"10.4103\/0301-4738.149134","type":"journal-article","created":{"date-parts":[[2015,1,12]],"date-time":"2015-01-12T05:13:04Z","timestamp":1421039584000},"page":"1136","source":"Crossref","is-referenced-by-count":3,"title":["A pharmacoeconomic analysis to determine the relative cost-effectiveness of bimatoprost 0.03% eye drops and brimonidine 0.2% eye drops in patients of primary open-angle glaucoma\/ocular hypertension"],"prefix":"10.4103","volume":"62","author":[{"given":"NavreetKaur","family":"Natt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0301-4738.149134-1","first-page":"57","volume-title":"Prevalence and distribution of glaucoma in central India (Glaucoma Survey 2001)","author":"Palimkar","year":"2008","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/0301-4738.149134-2","unstructured":"Murthy GV, Gupta S, Tewari HK, Jose R, Bachani D. National Survey on Blindness and Visual Outcomes after Cataract Surgery; 2001-2002. Report. New Delhi: National Programme for Control of Blindness, Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India; 2002."},{"key":"key-10.4103\/0301-4738.149134-3","unstructured":"Park K. Noncommunicable diseases: Blindness. In: Park\u2032s Textbook of Preventive and Social Medicine. 19 th ed. Jabalpur: Banarsidas Bhanot Publishers; 2007. p. 336-62."},{"key":"key-10.4103\/0301-4738.149134-4","first-page":"389","volume-title":"Number of people with glaucoma worldwide","author":"Quigley","year":"1996","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.149134-5","first-page":"844","volume-title":"Global data on visual impairment in the year 2002","author":"Resnikoff","year":"2004","journal-title":"Bull World Health Organ"},{"key":"key-10.4103\/0301-4738.149134-6","unstructured":"Shields MB. Classification of the glaucomas. In: Textbook of Glaucoma. 5 th ed. Baltimore: Lippincott Williams and Wilkins; 2005. p. 155-62."},{"key":"key-10.4103\/0301-4738.149134-7","first-page":"25","volume-title":"Profile of glaucoma in a major eye hospital in north India","author":"Das","year":"2001","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/0301-4738.149134-8","first-page":"48","volume-title":"Factors for glaucoma progression and the effect of treatment: The early manifest glaucoma trial","author":"Leske","year":"2003","journal-title":"Arch Ophthalmol"},{"key":"key-10.4103\/0301-4738.149134-9","first-page":"33","volume-title":"Prostaglandin analogues for ophthalmic use: A cost-effectiveness analysis","author":"Lachaine","year":"2008","journal-title":"Can J Ophthalmol"},{"key":"key-10.4103\/0301-4738.149134-10","first-page":"7","volume-title":"The efficacy and harm of prostaglandin analogues for IOP reduction in glaucoma patients compared to dorzolamide and brimonidine: A systematic review","author":"Hodge","year":"2008","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.149134-11","first-page":"A prospective, unmasked study","volume-title":"Comparison of the effects of brimonidine 0.2% and timolol 0","author":"Tsai","year":"5% o","journal-title":""},{"key":"key-10.4103\/0301-4738.149134-12","unstructured":"Gray JA. Evidence-based healthcare. In: How to Make Health Policy and Management Decisions? 2 nd ed. Edinburgh: Churchill Livingstone; 2001."},{"key":"key-10.4103\/0301-4738.149134-13","doi-asserted-by":"crossref","unstructured":"Drummond MF, Richardson WS, O\u2032Brien BJ, Levine M, Heyland D. Users\u2032 guides to the medical literature. XIII. How to use an article on economic analysis of clinical practice. A. Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 1997;277:1552-7.","DOI":"10.1001\/jama.1997.03540430064035"},{"key":"key-10.4103\/0301-4738.149134-14","first-page":"790","volume-title":"Mechanism of action of bimatoprost, latanoprost, and travoprost in healthy subjects.A crossover study","author":"Lim","year":"2008","journal-title":"Ophthalmology"},{"key":"key-10.4103\/0301-4738.149134-15","first-page":"757","volume-title":"Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: A crossover, observer-masked, three-centre study","author":"Konstas","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.149134-16","doi-asserted-by":"crossref","unstructured":"Day DG, Sharpe ED, Beischel CJ, Jenkins JN, Stewart JA, Stewart WC. Safety and efficacy of bimatoprost 0.03% versus timolol maleate 0.5%\/dorzolamide 2% fixed combination. Eur J Ophthalmol 2005;15:336-42.","DOI":"10.1177\/112067210501500304"},{"key":"key-10.4103\/0301-4738.149134-17","first-page":"85","volume-title":"Health economic evaluation","author":"Shiell","year":"2002","journal-title":"J Epidemiol Community Health"},{"key":"key-10.4103\/0301-4738.149134-18","first-page":"16","volume-title":"Pharmacoeconomic analysis of prostaglandin and prostamide therapy for patients with glaucoma or ocular hypertension","author":"Frenkel","year":"2007","journal-title":"BMC Ophthalmol"},{"key":"key-10.4103\/0301-4738.149134-19","first-page":"117","volume-title":"Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension","author":"Galanopoulos","year":"2009","journal-title":"Clin Ophthalmol"},{"key":"key-10.4103\/0301-4738.149134-20","first-page":"123","volume-title":"Comparison between latanoprost and brimonidine efficacy and safety in Indian eyes","author":"Thomas","year":"2003","journal-title":"Indian J Ophthalmol","ISSN":"https:\/\/id.crossref.org\/issn\/0301-4738","issn-type":"print"},{"key":"key-10.4103\/0301-4738.149134-21","first-page":"57","volume-title":"A randomised, double masked, multicentre clinical trial comparing bimatoprost and timolol for the treatment of glaucoma and ocular hypertension","author":"Whitcup","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"key-10.4103\/0301-4738.149134-22","first-page":"426","volume-title":"Cost considerations of medical therapy for glaucoma","author":"Fiscella","year":"1999","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.149134-23","first-page":"106","volume-title":"Cost analysis of glaucoma medications","author":"Rylander","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.149134-24","first-page":"18","volume-title":"Medical therapy cost considerations for glaucoma","author":"Fiscella","year":"2003","journal-title":"Am J Ophthalmol"},{"key":"key-10.4103\/0301-4738.149134-25","first-page":"379","volume-title":"Cost-effectiveness of antihypertensive drugs most commonly used in glaucoma","author":"Galindo-Ferreiro","year":"2004","journal-title":"Arch Ophthalmol Soc Esp"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T19:29:17Z","timestamp":1786649357000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0301-4738.149134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":25,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014]]}},"alternative-id":["149134"],"URL":"https:\/\/doi.org\/10.4103\/0301-4738.149134","relation":{},"ISSN":["0301-4738"],"issn-type":[{"value":"0301-4738","type":"print"}],"subject":[],"published":{"date-parts":[[2014]]}}}